Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its availability have become key concerns for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its expensive nature presents a significant barrier